Fingerprint
Dive into the research topics of 'A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer
John J. Weitz, Robert F. Marschke, Jeff A. Sloan, Joseph P. Grill, James R. Jett, James A. Knost, Alan K. Hatfield, David W. Zenk, Walter W. Bate, Paul L. Schaefer
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations